Claude Science seen as Anthropic's bid to own life sciences' economic version control
teortaxesTex · x · 2026-10-28
A thread analyzing Anthropic's Claude Science strategy:
- lefttailguy: Claude Science looks like a bid to own the "economic version control system" for life sciences. The endgame: Anthropic financing hundreds of drug programs in parallel for biopharmas using its harness, in exchange for clinical data rights—data that improves future financing and eventually feeds a "God Model" enabling an "AI drug factory."
- Will Manidis: the pharma company as such is the first primitive biology must lose; drug programs are baskets of risk and the ideal is vanishingly asset-light. "Learning on" or "zero-shotting" biology will yield new mechanistic abstractions.
- Context: roon predicts stunning advances in biology within a few years, with near-term solutions to cancer and neurodegenerative disease plausible.
A substantive discussion on AI-for-science business models and paradigm shifts in biology.
More from AGI Musings
- CS professor: if you never learned to write well yourself, how can you judge LLM-assisted papers? — CSProfKGD · 2026-10-28
- PhD thesis appendix 'Behind the Scenes' tradition reveals the confusion behind polished papers — benno_krojer · 2026-10-28
- AI Safety Crisis Is Here: Jarovsky Calls for Tech, Legal and Regulatory Action at Once — LuizaJarovsky · 2026-10-28
- Formation Bio raises $600M fund to scale AI-powered drug development — a16z · 2026-10-28
- Economist: AI gives every restaurant owner a free expert in law, tax and ads — paulnovosad · 2026-10-28
- Paper: AI and the Enclosure of the Scientific Commons — allpossiblepaths · 2026-10-28